On the Functional Significance of the P1 and N1 Effects to Illusory Figures in the Notch Mode of Presentation

The processing of Kanizsa figures have classically been studied by flashing the full “pacmen” inducers at stimulus onset. A recent study, however, has shown that it is advantageous to present illusory figures in the “notch” mode of presentation, that is by leaving the round inducers on screen at all times and by removing the inward-oriented notches delineating the illusory figure at stimulus onset. Indeed, using the notch mode of presentation, novel P1and N1 effects have been found when comparing visual potentials (VEPs) evoked by an illusory figure and the VEPs to a control figure whose onset corresponds to the removal of outward-oriented notches, which prevents their integration into one delineated form. In Experiment 1, we replicated these findings, the illusory figure was found to evoke a larger P1 and a smaller N1 than its control. In Experiment 2, real grey squares were placed over the notches so that one condition, that with inward-oriented notches, shows a large central grey square and the other condition, that with outward-oriented notches, shows four unconnected smaller grey squares. In response to these “real” figures, no P1 effect was found but a N1 effect comparable to the one obtained with illusory figures was observed. Taken together, these results suggest that the P1 effect observed with illusory figures is likely specific to the processing of the illusory features of the figures. Conversely, the fact that the N1 effect was also obtained with real figures indicates that this effect may be due to more global processes related to depth segmentation or surface/object perception

Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Objective To examine whether a history of sexually transmitted infections (STIs) or positive STI serology is associated with prevalent and incident benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)-related outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Methods Self-reported history of STIs (gonorrhoea, syphilis) was ascertained at baseline, and serological evidence of STIs (Chlamydia trachomatis, Trichomonas vaginalis, human papillomavirus (HPV)-16, HPV-18, herpes simplex virus type 2, human herpesvirus type 8 and cytomegalovirus) was detected in baseline serum specimens. We used data collected on the baseline questionnaire, as well as results from the baseline prostate-specific antigen (PSA) test and digital rectal examination (DRE), to define prevalent BPH/LUTS-related outcomes as evidence of LUTS (self-reported diagnosis of an enlarged prostate/BPH, BPH surgery or nocturia [waking ≥2 times/night to urinate]) and evidence of prostate enlargement (PSA > 1.4 ng/mL or prostate volume ≥30 mL) in men without prostate cancer. We created a similar definition of incident BPH using data from the follow-up questionnaire completed 5-13 years after enrolment (self-reported diagnosis of an enlarged prostate/BPH or nocturia), data on finasteride use during follow-up, and results from the follow-up PSA tests and DREs. We used Poisson regression with robust variance estimation to calculate prevalence ratios (PRs) in our cross-sectional analysis of self-reported (n = 32 900) and serologically detected STIs (n = 1 143) with prevalent BPH/LUTS, and risk ratios in our prospective analysis of self-reported STIs with incident BPH/LUTS (n = 5 226). Results Generally null results were observed for associations of a self-reported history of STIs and positive STI serologies with prevalent and incident BPH/LUTS-related outcomes, with the possible exception of T. vaginalis infection. This STI was positively associated with prevalent nocturia (PR 1.36, 95% confidence interval (CI) 1.18-1.65), prevalent large prostate volume (PR 1.21 95% CI 1.02-1.43), and any prevalent BPH/LUTS (PR 1.32 95% CI 1.09-1.61); too few men had information on both STI serologies and incident BPH/LUTS to investigate the associations between T. vaginalis infection and incident BPH/LUTS-related outcomes. Conclusions Our findings do not support associations of several known STIs with BPH/LUTS-related outcomes, although T. vaginalis infection may warrant further study

Migratory timing, rate, routes and wintering areas of White-crested Elaenia (Elaenia albiceps chilensis), a key seed disperser for Patagonian forest regeneration.

Migratory animals often play key ecological roles within the communities they visit throughout their annual journeys. As a consequence of the links between biomes mediated by migrants, changes in one biome could affect remote areas in unpredictable ways. Migratory routes and timing of most Neotropical austral migrants, which breed at south temperate latitudes of South America and overwinter closer to or within tropical latitudes of South America, have yet to be described in detail. As a result, our understanding about how these birds provide links between South American biomes is almost non-existent. White-crested Elaenia (Elaenia albiceps chilensis) is a long-distance austral migrant that breeds in the Patagonian Forest biome and overwinters in tropical South America. Because this small flycatcher plays a key role in the regeneration of this ecosystem, our objective was to describe the annual cycle of White-crested elaenias to evaluate the degree of migratory connectivity between breeding and wintering areas and therefore to determine if there are specific biomes of northern South America linked by elaenias to Patagonian forests. Fifteen individuals were successfully tracked throughout a complete migration cycle using miniature light-level geolocators. All individuals resided and moved through the same general regions. During fall (March-April-May), elaenias were located in the Caatinga and the Atlantic Forest biomes, from Rio de Janeiro to the region near Salvador da Bahia, Brazil. During winter (June-July-Aug.), birds were located further inland, within the Cerrado biome. Birds used three different routes during fall migration. Our results indicate that some individuals use a direct route, flying between 500-600 km/day, crossing desert and grasslands, while others took a detour, flying 100-200 km/day through forested areas with refueling opportunities. All birds used the Yunga forest during spring migration, with ten out of 15 individuals showing a clear counterclockwise loop trajectories throughout their annual cycle. None of the elaenias passed through Amazonia, traveled to western South America or crossed the Equator. Eleanias exhibited a high migratory connectivity between breeding area in Patagonian Forests and winter areas, Atlantic Forest and Cerrado. Our results suggest that Patagonian Forests could be strongly impacted by changes in those biomes or in the Yungas

Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities

Multiple myeloma is a plasma cell skeletal malignancy. While therapeutic agents such as bortezomib and lenalidomide have significantly improved overall survival, the disease is currently incurable with the emergence of drug resistance limiting the efficacy of chemotherapeutic strategies. Failure to cure the disease is in part due to the underlying genetic heterogeneity of the cancer. Myeloma progression is critically dependent on the surrounding microenvironment. Defining the interactions between myeloma cells and the more genetically stable hematopoietic and mesenchymal components of the bone microenvironment is critical for the development of new therapeutic targets. In this review, we discuss recent advances in our understanding of how microenvironmental elements contribute to myeloma progression and therapeutically, how those elements can or are currently being targeted in a bid to eradicate the disease